Two leading figures whose work has helped shape diabetes research, prevention and care have been recognised in a prestigious ...

A new wearable microsensor designed to make glucose monitoring less invasive could be available in Europe within the next two ...

NHS Trust has been presented with the Insulin Safety Week Excellence Award in recognition of its outstanding contribution to ...

New guidance on the management of type 1 diabetes in adults has put greater emphasis on accurate diagnosis amid concerns that ...

Thousands of people living with diabetes could be missing out on early detection of chronic kidney disease because of low uptake of a simple urine test, kidney health experts have warned. Despite ...

New research published in The Lancet Regional Health Americas shows that around half of people diagnosed with early-onset type 2 diabetes before the age of 45 can achieve remission through a ...

The Diabetes & Obesity Pharmacy Alliance is launching a series of free webinars to help pharmacists navigate the evolving landscape of diabetes and obesity care, with sessions exploring injectable ...

People with type 1 diabetes using multiple daily injections who respond more consistently to smart insulin pen alerts could ...

The organisers of an inaugural conference which will bring together experts in diabetes, cardiovascular, renal and metabolic care have issued a final call to secure one of the last remaining tickets.

New guidelines to improve the quality of care for people with diabetes living in care homes have been released. They provide a series of indicators that can help inspectors to assess whether a service ...

You can sign in with OneKey / OWA to view this content.

Ozempic ® (semaglutide), a new once-weekly GLP-1 analogue injection for the treatment of type 2 diabetes, is now available in the UK, Novo Nordisk UK has announced. It works by mimicking the function ...